NSC |
Compound |
Enrichment |
Correlation |
NSC 339638 |
2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt |
0.0241085022307781 |
0.30479624 |
NSC 622398 |
Fascaplysine |
0.0241085022307781 |
0.28516933 |
NSC 626540 |
1,3-Propanediamine, N-(2-chloroethyl)-N'-(2-methoxy-9- acridinyl)-N-methyl-, dihydrochloride |
0.0241085022307781 |
0.28349462 |
NSC 626673 |
Null |
0.0241085022307781 |
0.38519894 |
NSC 639503 |
Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride |
0.0241085022307781 |
0.37574802 |
NSC 641233 |
2-Naphthalenebutanamide, N-(3-chloro-1,4-dihydro- 1,4-dioxo-2-naphthalenyl)-.beta.-(1,3-dihydro-3-oxo- 1-isoindolyl)-.alpha.-,-.gamma.-dioxo- |
0.0241085022307781 |
0.18512136 |
NSC 642913 |
Null |
0.0241085022307781 |
0.096299259 |
NSC 643813 |
3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] |
0.0241085022307781 |
0.13916 |
NSC 646610 |
Null |
0.0241085022307781 |
0.028108852 |
NSC 648100 |
Null |
0.0241085022307781 |
0.41081378 |